|
Comparison of the PSA and ANN velocity in PCa and BPH patients |
||||||
| PSA velocity (PSAV) |
ANN velocity (ANNV) |
|||||
|
|
||||||
| follow up group |
PCa in % (n = 49) |
BPH in % (n = 150) |
PCa in % (n = 49) |
Difference to PSAV |
BPH in % (n = 150) |
Difference to PSAV |
|
|
||||||
| increasing |
71.4% |
21.3% |
44.9% |
- 26.5% |
10.7% |
- 10.6% |
| stable* |
18.4% |
65.3% |
34.7% |
+ 16.3% |
82.7% |
+ 17.4% |
| decreasing |
10.2% |
13.3% |
20.4% |
+ 10.2% |
6.7% |
- 6.6% |
|
*by using the cutoff of 0.75 ng/mL/year for tPSA (range -0.75 to 0.75) and by using the cutoff of 4 per year for ANN output (range -4 to 4) | ||||||
Stephan et al. BMC Urology 2008 8:10 doi:10.1186/1471-2490-8-10 |
||||||